ArticleNature communications2020

A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction.

Monir Ejemel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.